Details
Stereochemistry | ACHIRAL |
Molecular Formula | C32H46N8O6S2 |
Molecular Weight | 702.888 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(CC1=C(N)N=C(C)N=C1)C=O)=C(\C)N(CC2=C(N)N=C(C)N=C2)C=O
InChI
InChIKey=CKHJPWQVLKHBIH-GPAWKIAZSA-N
InChI=1S/C32H46N8O6S2/c1-19(2)31(43)45-11-9-27(21(5)39(17-41)15-25-13-35-23(7)37-29(25)33)47-48-28(10-12-46-32(44)20(3)4)22(6)40(18-42)16-26-14-36-24(8)38-30(26)34/h13-14,17-20H,9-12,15-16H2,1-8H3,(H2,33,35,37)(H2,34,36,38)/b27-21+,28-22+
Molecular Formula | C32H46N8O6S2 |
Molecular Weight | 702.888 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/21204296Curator's Comment: description was created based on several sources, including
https://www.unitedpharmacies.com/Arcalion-Sulbutiamine.html
https://www.ncbi.nlm.nih.gov/pubmed/12973384
http://www.smartnootropics.co.uk/sulbutiamine/
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21204296
Curator's Comment: description was created based on several sources, including
https://www.unitedpharmacies.com/Arcalion-Sulbutiamine.html
https://www.ncbi.nlm.nih.gov/pubmed/12973384
http://www.smartnootropics.co.uk/sulbutiamine/
Sulbutiamine (isobutyryl thiamine disulfide) is a lipophilic derivative of thiamine. It is available over-the-counter in several countries either as a component of nutritional supplements or as a pharmaceutical preparation. Arcalion (Sulbutiamine) is prescribed as a treatment to help patients with a range of conditions such as asthenia, chronic fatigue, diabetes, hypothyroidism, renal disease, fibromyalgia, and depression (post partum). It remedies the symptoms of weakness by increasing focus, strength (both physical and mental), and energy, making you more alert, less lethargic, and more upbeat whilst also helping to stabilize sleeping patterns. In addition, this medication can also help a patient`s memory, and strengthen thinking processes. Some patient`s have even reported slight eyesight improvements. This product is also popular with athletes as a nutritional supplement as it is a vitamin compound which will not show up in competitive sports blood testing. It can help to achieve your maximum potential and replenish energy after strenuous activities, making it possible to maintain your edge. The presence of sulbutiamine in urinary doping control samples was monitored to evaluate the relevance of its use in sports. The motivating, confidence enhancing effects of sulbutiamine are thought to be related to its ability to enhance dopamine sensitivity. In animal models sulbutiamine has been shown to increase the number of dopamine binding sites (specifically D1) in the prefrontal cortex, this effect is achieved through reduction of dopamine release. Sulbutiamine could be best thought of as a dopamine modulator rather than a compound that directly inhibits or enhances the release of dopamine. Additionally sulbutiamine has been found to enhance memory, possibly by cholinergic transmission. Research indicates that high affinity choline uptake (HACU) was moderately increased in rodent brains following sulbutiamine consumption. However it should be noted the doses used were high (300 mg/kg).
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/22040892
Curator's Comment: can cross the blood-brain barrier easily
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20809085
Sulbutiamine dose-dependently attenuated apoptotic cell death induced by serum deprivation and stimulated GSH and GST activity. Moreover, sulbutiamine decreased the expression of cleaved caspase-3 and AIF
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:36:57 GMT 2023
by
admin
on
Fri Dec 15 15:36:57 GMT 2023
|
Record UNII |
42NCM1BW43
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C45812
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
||
|
WHO-VATC |
QA11DA02
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
||
|
DSLD |
3147 (Number of products:20)
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
||
|
WHO-ATC |
A11DA02
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB10679MIG
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
3286-46-2
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
4827
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
37317
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID5046641
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
C152450
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
3002120
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
2494
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
221-937-3
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
SULBUTIAMINE
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
m10719
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
42NCM1BW43
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105813
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
DB13416
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
C031331
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY | |||
|
100000087090
Created by
admin on Fri Dec 15 15:36:57 GMT 2023 , Edited by admin on Fri Dec 15 15:36:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |